H7 Q226L In Shanghai and Anhui H7N9 Cases



	Home	Founder	What's New	In The News	Consulting



H1N1 Consulting Paradigm Shift Viral Evolution Intervention Monitoring Vaccine Screening Vaccine Development Expression Profiling Drug Discovery Custom Therapies Patents	Audio:Jan24 Feb11 Feb21 Mar21 twitter Commentary H7 Q226L In Shanghai and Anhui H7N9 Cases Recombinomics Commentary 20:15 April 1, 2013 The recent H7N9 cases in China have caused considerable concern. This serotype had never been found in humans previously and only one fatal bird flu case that was not H5N1 had been reported (H7N7 in The Netherlands in 2003. Two of the H7N9 cases were fatal (87M and 27M), while one was critical (35F). The WHO Chinese Influenza Research Center released a full set of sequences for all three cases. Each had PB2 E627K, as well as a 15 BP deletion In N9. PB2 E627K is a mammalian adaptation and was present in both H5N1 transmission experiments (CDC and EMC) which used an avian PB2. All three of the H5N1 transmission studies introduced the receptor bind domain change Q226L to increase affinity for mammalian receptors. Q226L has never been reported in natural H5N1 isolates. Two of the H7N9 cases, A/Shanghai/2/2013 and A/Anhui/1/2013 have Q226L, raising serious pandemic concerns. Media Link Recombinomics Presentations Recombinomics Publications Recombinomics Paper at Nature Precedings